Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
27 avr. 2023 08h30 HE
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., April 27, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will...